Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/787
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWhitty, Jennifer A.en
dc.contributor.authorEllwood, Daviden
dc.contributor.authorStapleton, Helenen
dc.contributor.authorChaboyer, Wendyen
dc.contributor.authorMahomed, Kassamen
dc.contributor.authorGillespie, Brigid M.en
dc.contributor.authorWebster, Joanen
dc.contributor.authorCullum, Nickyen
dc.contributor.authorThalib, Lukmanen
dc.date.accessioned2018-08-17T21:09:21Z-
dc.date.available2018-08-17T21:09:21Z-
dc.date.issued2016en
dc.identifier.citation02/0110/18/received |11/19/revised |12/23/accepted | 6, (2), 2016, p. e010287en
dc.identifier.otherRISen
dc.identifier.urihttp://dora.health.qld.gov.au/qldresearchjspui/handle/1/787-
dc.description.abstractINTRODUCTION: Obese women are more likely to develop a surgical site infection (SSI) following caesarean section (CS) than non-obese women. Negative pressure wound therapy (NPWT) is increasingly being used to reduce SSI with limited evidence for its effectiveness. OBJECTIVES: To determine the clinical and cost-effectiveness of using NPWT in obese women having elective and semiurgent CS. METHODS AND ANALYSIS: A multisite, superiority parallel pragmatic randomised controlled trial with an economic evaluation. Women with a body mass index (BMI) of ≥30, booked for elective and semiurgent CS at 4 Australian acute care hospitals will be targeted. A total of 2090 women will be enrolled. A centralised randomisation service will be used with participants block randomised to either NPWT or standard surgical dressings in a 1:1 ratio, stratified by hospital. The primary outcome is SSI; secondary outcomes include type of SSI, length of stay, readmission, wound complications and health-related quality of life. Economic outcomes include direct healthcare costs and cost-effectiveness, which will be evaluated using incremental cost per quality-adjusted life year gained. Data will be collected at baseline, and participants followed up on the second postoperative day and weekly from the day of surgery for 4 weeks. Outcome assessors will be masked to allocation. The primary statistical analysis will be based on intention-to-treat. ETHICS AND DISSEMINATION: Ethics approval has been obtained from the ethics committees of the participating hospitals and universities. The findings of the trial will be disseminated through peer-reviewed journals, national and international conference presentations. TRIAL REGISTRATION NUMBER: ACTRN12615000286549; Pre-results.bmjopen-2015-010287[PII]26832435[pmid] <br />BMJ Open <br />en
dc.languageenen
dc.relation.ispartofBMJ Openen
dc.titleADding negative pRESSure to improve healING (the DRESSING trial): a RCT protocolen
dc.typeArticleen
dc.identifier.doi10.1136/bmjopen-2015-010287en
dc.relation.urlhttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746446/en
dc.identifier.risid103en
dc.description.pagese010287en
item.openairetypeArticle-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
Appears in Sites:West Moreton HHS Publications
Show simple item record

Page view(s)

334
checked on Nov 22, 2024

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.